The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Providing uninterrupted oral oncolytic therapies during the COVID-19 pandemic.
 
Edward Arrowsmith
Employment - Tennessee Oncology
Stock and Other Ownership Interests - OneOncology
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Calistoga Pharmaceuticals (Inst); Celgene (Inst); Cephalon (Inst); Chorus (Inst); Clovis Oncology (Inst); Cougar Biotechnology (Inst); Eisai (Inst); EMD Serono (Inst); Evelo Biosciences (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen Research & Development (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Modra Pharmaceuticals (Inst); Novartis (Inst); Oncogenex (Inst); Onyx (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Sarah Cannon Research Institute (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Flatiron Health; OneOncology; Sarah Cannon Research Institute
Other Relationship - Sarah Cannon Research Institute
 
Rachel L. Mitchell
No Relationships to Disclose
 
Jack L. Taylor
No Relationships to Disclose
 
Stephen Matthew Schleicher
Employment - Tennessee Oncology
Leadership - OneOncology
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Magnolia Innovation; Rigel
Research Funding - Tennessee Oncology
Travel, Accommodations, Expenses - Flatiron Health; Magnolia Innovation; Rigel; Tennessee Oncology
 
Natalie R. Dickson
Employment - Tennessee Oncology
Consulting or Advisory Role - Abbvie; Synergy Health (Hong Kong) Limited; Via Oncology
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Flatiron Health; Flatiron Health
 
Stacey McCullough
Consulting or Advisory Role - Abbvie; Bayer; BeiGene; Blueprint Medicines; Daiichi Sankyo; Epizyme; G1 Therapeutics; GlaxoSmithKline; Immunomedics; Verastem
Speakers' Bureau - Teva